NIAID: Recent Advances in Biomarkers of Allergy and Asthma
Friday, February 28, 2014: 2:00 PM-5:00 PM
Convention Center, Upper Level, Room 11AB
2.75 CME/ 3.30 CE
Marshall Plaut , MD FAAAAI
Learning Objectives:
  1. Explain how mediators produced following allergen challenge predict the status of allergic diseases
  2. Describe the relationship of successful allergen immunotherapy to effects on circulating T cell subsets and antibody responses
  3. Appreciate the value of measuring peripheral blood basophil activation in allergic diseases and asthma
2:00 PM
Allergen Challenge as a Biomarker of Disease Severity and of the Effects of Treatment
Stephen R. Durham, MA MD FRCP
2:25 PM
Transcriptomic Changes After Allergen Exposure
Sunil K. Ahuja, MD
2:50 PM
Basophil Activation as a Predictor of Food Allergen Severity
Alexandra F. Santos, MD MSc
3:15 PM
3:30 PM
Basophil Activation as a Biomarker of Food Allergy and Asthma
Wayne G. Shreffler, MD PhD FAAAAI
3:55 PM
T Regulatory Cells as Markers of Allergen Immunotherapy
Andrew D. Luster, MD PhD
4:20 PM
CD27 Effector Cell Depletion During Allergen Immunotherapy
Erik R. Wambre, PhD
  • handout AAAAI wambre.pdf (290.9 kB)
  • 4:45 PM
    Question & Answer
    See more of: Course